Biostimulators: PLLA and CaHA explained
Poly-L-lactic acid (PLLA) and calcium hydroxylapatite (CaHA) are injectable materials discussed for correction and collagen-related effects. They differ from hyaluronic acid and from each other.
The material changes the result pattern
PLLA is a resorbable synthetic polymer whose visible correction develops gradually over weeks. CaHA consists of mineral particles in a gel carrier. Product preparation, placement and intended use affect what treatment aims to achieve. Immediate swelling should not be confused with the eventual result.
Look for the exact clinical indication
A U.S. FDA evaluation supports a specific PLLA product for cheek wrinkles; it does not validate every PLLA brand, injection site or dilution. Similarly, a general CaHA label does not explain a hyperdiluted protocol. Ask which human data match the preparation and area being proposed in your country.
Discuss correction as well as benefit
These materials should not be presented as a universal replacement for HA or as a guarantee against unwanted fullness. Nodules, infection and vascular complications are relevant to injectable decisions. Reduction or removal may be difficult and they are not dissolved in the same way as HA. Ask how an unwanted result would be assessed and managed before treatment.
“Why does this material and preparation fit my goal and what are the options if the result is unwanted?”
Read the original sources
General education. Your clinician can assess your individual suitability. Rules depend on the treatment country; FDA references concern the United States. External sources may be in another language.